TrialJournal of acquired immune deficiency syndromes (1999)2014

Pilot study of pioglitazone before HCV retreatment in HIV/HCV genotype 1-infected subjects with insulin resistance and previous nonresponse to peginterferon and ribavirin therapy: A5239.

Kristen M Marks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.